Dopamine-Dependent Iron Toxicity in Cells Derived from Rat Hypothalamus
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
We report a new and specific mechanism for iron-mediated neurotoxicity using RCHT cells, which were derived from rat hypothalamus. RCHT cells exhibit immunofluorescent-positive markers for dopamine beta-hydroxylase and the norepinephrine transporter, NET. In the present study, we observed that iron-induced neurotoxicity in RCHT cells was dependent on (i) formation of an Fe-dopamine complex (100 microM FeCl3:100 microM dopamine); (ii) specific uptake of the Fe-dopamine complex into RCHT cells via NET (79+/-2 pmol 59Fe/mg/min; P<0.05), since the uptake of the 59Fe-dopamine complex by the cells was inhibited by 30 microM reboxetine, a specific NET inhibitor (78% inhibition, P<0.001); and (iii) intracellular oxidation of dopamine present in the Fe-dopamine complex to aminochrome; (iv) inhibition of DT-diaphorase, since incubation of RCHT cells with 100 microM Fe-dopamine complex in the presence of 100 microM dicoumarol, an inhibitor of DT-diaphorase, induced significant cell death (51+/-5%; P<0.001). However, this cell death was reduced by 75% when the cells were incubated in the presence of 30 microM reboxetine (P<0.01). No significant cell death was observed when the cells were incubated with 100 microM dopamine, 100 microM Fe-Dopamine complex, 100 microM dicoumarol, or 100 microM FeCl3 (8.3+/-2, 9+/-4, 8.5+/-3, or 9.7+/-2% of control, respectively). ESR studies using the spin trapping agent DMPO showed no formation of hydroxyl radicals when the cells were incubated with 100 microM FeCl3 alone. However, using the same ESR technique, the formation of hydroxyl radicals and a carbon-centered radical was detected when the cells were incubated with 100 microM Fe-dopamine complex in the presence of 100 microM dicoumarol. These studies suggest that iron can induce cell toxicity by a mechanism that requires the formation and NET-mediated uptake of an Fe-dopamine complex, ultimately resulting in the intracellular formation of reactive species.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although dopamine is capable of reacting with iron directly to form a toxic complex (Arreguin et al. 2009; Paris et al. 2005) that probably itself catalyses hydroxyl formation.”
In the citing paper
“Cathecolamines, such as dopamine, might be oxidised to highly reactive or toxic quinones via the reduction of ferric iron or enzymatically.65–67”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [67]
Citations
Cites
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 752
Sulzer, D., Bogulavsky, J., Larsen, K. E., Behr, G., Karatekin, E., Kleinman, M. H., Turro, N., Krantz, D., Edwards, R. H., Greene, L. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.11869 · Cited by 407
Berg, D., Roggendorf, W., Schröder, U., Klein, R., Tatschner, T., Benz, P., Tucha, O., Preier, M., Lange, K. W., Reiners, K., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.999 · Cited by 377
Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease
Gorell, J. M., Ordidge, R. J., Brown, G. G., Deniau, J.-C., Buderer, N. M., & Helpern, J. A. (1995) · Neurology · doi:10.1212/wnl.45.6.1138 · Cited by 324
Morita, H., Ikeda, S., Yamamoto, K., Morita, S., Yoshida, K., Nomoto, S., Kato, M., & Yanagisawa, N. (1995) · Annals of Neurology · doi:10.1002/ana.410370515 · Cited by 246
Linert, W., Herlinger, E., Jameson, R. F., Kienzl, E., Jellinger, K., & Youdim, M. B. H. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(96)00020-8 · Cited by 238
Segura-Aguilar, J., & Lind, C. (1989) · Chemico-Biological Interactions · doi:10.1016/0009-2797(89)90006-9 · Cited by 192
Self-citationProta, G. (2000) · Pigment Cell Research · doi:10.1034/j.1600-0749.2000.130412.x · Cited by 134
Segura‐Aguilar, J., Metodiewa, D., & Welch, C. J. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(98)00036-1 · Cited by 131
Self-citationParis, I., Dagnino‐Subiabre, A., Marcelain, K., Bennett, L. B., Caviedes, P., Caviedes, R., Azar, C. O., & Segura‐Aguilar, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00243.x · Cited by 129
Self-citationArriagada, C., Paris, I. B., Matas, M. J. S. D. L., Martinez-Alvarado, P., Cárdenas, S., Castañeda, P., Graumann, R., Perez-Pastene, C., Olea‐Azar, C., Couve, E., et al. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.014 · Cited by 123
Self-citationGerlach, M., Double, K. L., Ben‐Shachar, D., Zecca, L., Youdim, M. B. H., & Riederer, P. F. (2003) · Neurotoxicity Research · doi:10.1007/bf03033371 · Cited by 116
Iron in neurodegenerative disorders
Berg, D., Becker, G., Riederer, P. F., & Rieß, O. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000045444 · Cited by 101
Increased plasma lipid peroxidation in patients with aceruloplasminemia
Miyajima, H., Takahashi, Y., Serizawa, M., Kaneko, E., & Gitlin, J. D. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02178-7 · Cited by 74
Graumann, R., Paris, I. B., Martinez-Alvarado, P., Rumanque, P., Perez-Pastene, C., Cárdenas, S., Marin, P., Díaz-Grez, F., Caviedes, R., Caviedes, P. A., et al. (2002) · PubMed · Cited by 72
Self-citationBaez, S., Linderson, Y., & Segura‐Aguilar, J. (1995) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1995.1002 · Cited by 71
Self-citationDíaz‐Véliz, G. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.10.016 · Cited by 52
Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson’s disease
Andersen, J. K. (2003) · Neurotoxicity Research · doi:10.1007/bf03033150 · Cited by 40
Smythies, J., Iuliis, A. D., Zanatta, L., & Galzigna, L. (2002) · Neurotoxicity Research · doi:10.1080/10298420290007655 · Cited by 31
Segura‐Aguilar, J., Metodiewa, D., & Baez, S. (2001) · Neurotoxicity Research · doi:10.1007/bf03033188 · Cited by 31
Self-citationSegura‐Aguilar, J., Díaz‐Véliz, G., Mora, S., & Herrera‐Marschitz, M. (2002) · Neurotoxicity Research · doi:10.1080/10298420290015926 · Cited by 25
Self-citationRoubert, C., Sagné, C., Kapsimali, M., Vernier, P., Bourrat, F., & Giros, B. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12607-7 · Cited by 24
Hernández, R. A., Matas, M. J. S. D. L., Arriagada, C., Barcia, C., Caviedes, P. A., Herrero, M. T., & Segura‐Aguilar, J. (2003) · Neurotoxicity Research · doi:10.1007/bf03033169 · Cited by 12
Self-citationNeurotoxicity of some MAO inhibitors in adult rat hypothalamic cell culture
Hurtado‐Guzmán, C., Martinez-Alvarado, P., Dagnino‐Subiabre, A., Paris, I. B., Caviedes, P. A., Caviedes, R., Cassets, B. K., & Segura‐Aguilar, J. (2002) · Neurotoxicity Research · doi:10.1080/10298420290015944 · Cited by 8
Self-citationMinzenberg, M. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_737 · Cited by 1
Research works printed but not linked: 6
- Dexter D. T., 1989, J. Neurochem., 52
- Linert W., 1996, Biochim. Biophys. Acta, 1316
- Segura-Aguilar J., 1998, Biochim. Biophys. Acta, 1381, 6
- Graumann R., 2002, Pol. J. Pharmacol., 54
- Smythies J., 2002, Neurotox. Res., 4, 81
- Sulzer D., 2000, Proc. Natl. Acad. Sci. U.S.A. 97
Cited by
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Oxidative Stress and Neurotoxicity
Sayre, L. M., Perry, G., & Smith, M. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 867
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
Self-citationProtective and toxic roles of dopamine in Parkinson's disease
Segura‐Aguilar, J., Paris, I., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 498
Self-citation8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications
Prachayasittikul, V., Prachayasittikul, V., Prachayasittikul, S., & Ruchirawat, S. (2013) · Drug Design, Development and Therapy · doi:10.2147/dddt.s49763 · Cited by 445
“35,36 Ladostigil contains the propargylamine moiety that accounts for its inhibition of the monoamine oxidase enzyme.”
Metadata
- Authors
- Paris, I., Martinez-Alvarado, P., Cárdenas, S., Perez-Pastene, C., Graumann, R., Fuentes, P., Olea-Azar, C., Caviedes, P., & Segura-Aguilar, J.
- Affiliations
- University of Chile (CL)
- Program of Molecular and Clinical Pharmacology, ICBM, Faculty of Medicine, and Department of Biophysics, Faculty of Chemistry and Pharmacy, University of Chile, Casilla 70000, Santiago-7, Chile
- Venue
- Chemical Research in Toxicology
- Publisher
- American Chemical Society (ACS)
- Published
- 2005-01-28
- Volume
- 18
- Issue
- 3
- Pages
- 415-419
- ISSN
- 0893-228X (ISSN-L)
- 1520-5010
- OpenAlex
- W2081705343
- Cited by
- 74
- References
- 26
- Citations by year
- 2026: 3 · 2025: 1 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 2 · 2012: 5
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- green
- americanae.aecid.es
- Licence
- other-oa
- Locations
- Chemical Research in Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Universidad de Chile (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Heavy Metal Exposure and Toxicity
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- iron toxicity, dopamine, neurotoxicity, norepinephrine transporter, hypothalamic neurons, DT-diaphorase, dicumarol, reboxetine, aminochrome, hydroxyl radicals, carbon-centered radicals, cell death, iron absorption, EPR spin trapping, DMPO, iron-59
- MeSH terms
- Reboxetine, Animals, Dicumarol, Cell Line, Chlorides, Dopamine, Dopamine beta-Hydroxylase, Ferric Compounds, Fluorescent Antibody Technique, Hypothalamus, Iron, Morpholines, Rats, Inbred F344, NAD(P)H Dehydrogenase (Quinone), Cell Death, Microscopy, Confocal, Adrenergic Uptake Inhibitors, Symporters, Indolequinones, Norepinephrine Plasma Membrane Transport Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.